Oncomine Myeloid RNA Panel

It is a next-generation sequencing test that analyses RNA expression profiles to identify gene mutations and abnormal gene expression in myeloid cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). It provides crucial information to help your doctor evaluate and manage related conditions.